Binding-induced, turn-on fluorescence of the EGFR/ERBB kinase inhibitor, lapatinib

James N. Wilson, Wenjun Liu, Adrienne S. Brown, Ralf Landgraf

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

We report the photophysical properties, binding-induced turn-on emission, and fluorescence imaging of the cellular uptake and distribution of lapatinib, an EGFR/ERBB inhibitor. Lapatinib, a type II, i.e. inactive state, inhibitor that targets the ATP binding pocket of the EGFR family of receptor tyrosine kinases. DFT calculations predict that the 6-furanylquinazoline core of lapatinib should exhibit an excited state with charge transfer character and an S0 to S1 transition energy of 3.4 eV. Absorption confirms an optical transition in the near UV to violet, while fluorescence spectroscopy shows that photoemission is highly sensitive to solvent polarity. The hydrophobicity of lapatinib leads to fluorescent aggregates in solution, however, binding to the lipid-carrier protein, BSA or to the kinase domain of ERBB2, produces spectroscopically distinct photoemission. Confocal fluorescence microscopy imaging of lapatinib uptake in ERBB2-overexpressing MCF7 and BT474 cells reveals pools of intracellular inhibitor with emission profiles consistent with aggregated lapatinib.

Original languageEnglish (US)
Pages (from-to)5006-5011
Number of pages6
JournalOrganic and Biomolecular Chemistry
Volume13
Issue number17
DOIs
StatePublished - May 7 2015

ASJC Scopus subject areas

  • Biochemistry
  • Physical and Theoretical Chemistry
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Binding-induced, turn-on fluorescence of the EGFR/ERBB kinase inhibitor, lapatinib'. Together they form a unique fingerprint.

  • Cite this